Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients
Biomarker Research(2024)
摘要
Metabolic dysfunction-associated steatotic liver disease (MASLD) is estimated to affect 30
更多查看译文
关键词
Biomarker,MASLD,Fibrosis,Proteomics,Liver
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要